
Favibluz 200mg Tablet
Marketer
Blue Cross Laboratories Ltd
Salt Composition
Favipiravir (200mg)
Overview Favibluz 200mg Tablet
Avigan 200mg tablets are an antiviral medication indicated for adults with mild to moderate COVID-19. This drug inhibits viral replication, thus reducing the body's viral burden. Always adhere to your physician's prescribed dosage and duration; avoid self-administration. Common adverse reactions may include elevated blood uric acid, diarrhea, neutropenia, and increased hepatic enzymes. Report any concerning side effects to your doctor immediately. Prior to initiating treatment, disclose any pre-existing severe hepatic or renal impairment to your doctor to ensure safe usage. Avigan 200mg tablets are contraindicated in pregnant or breastfeeding women, and those suspected of pregnancy, due to potential harm to the fetus. Additionally, inform your doctor of any prior hypersensitivity to this medication, uric acid metabolic disorders, or gout.
Uses of Favibluz 200mg Tablet
Managing Coronavirus Disease 2019 (COVID-19)
Major Benefits of Favibluz 200mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 200mg Favibluz Tablet should be swallowed whole; do not crush, chew, or break it. While it can be taken with or without food, consistency in timing is recommended.
Common Side effects of Favibluz 200mg Tablet:
- Increased uric acid level in blood
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Increased liver enzymes
- Increased triglyceride level in blood
How to use Favibluz 200mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consumption of the Favibluz 200mg Tablet may coincide with meals or be taken independently, although consistent timing is recommended.
How Favibluz 200mg Tablet works:
Favipiravir 200mg tablets exhibit antiviral properties, inhibiting SARS-CoV-2 replication. This action reduces the viral burden, thereby limiting transmission and accelerating patient recovery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Favibluz 200mg tablets may pose safety risks; a physician's advice is recommended.
PregnancyUNSAFE
Pregnant individuals should absolutely avoid Favibluz 200mg Tablets. Research in animals and pregnant women reveals substantial risks to fetal development; consult a physician before use.
Breast feedingUNSAFE
Merrem 200mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCONSULT YOUR DOCTOR
Driving ability may be affected by Favibluz 200mg Tablet, though this is unconfirmed. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with severe kidney impairment should use Favibluz 200mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Favibluz 200mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Favibluz 200mg Tablet :
Should you forget a Favibluz 200mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Favibluz 200mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Pyrazine carboxamide-based compound |
| Potential for Dependence | None. |
| Type of Medication | Agents against infection |
